Feature | Treatment Planning | July 07, 2022 | Information provided by Grand View Research
Accuray Precision Treatment Planning System For CyberKnife

Accuray Precision Treatment Planning System For CyberKnife


The global treatment planning systems and advanced image processing market size was valued at USD 1.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2030, according to new data from Grand View Research. The growing prevalence of cancer and increasing medical imaging procedures are driving the demand, which in turn is anticipated to drive the market growth over the forecast years. The growing demand for innovative and accurate cancer treatment using advanced image processing technology is further supporting to the rising penetration of the market all over the globe. Evolving healthcare IT infrastructure and growing adoption of machine learning (ML) and artificial intelligence (AI) for oncology treatment practices is also fueling market growth.

Growing Prevalence of Cancer

The increasing focus of the market players to invest in the innovation of advanced technology in order to hold a strong position in the global market is also anticipated to accelerate market growth. The rapidly increasing mortalities due to cancer at both regional and global levels is boosting the demand for advanced and innovative treatment practices. For instance, as per 2020 Globocan estimates, about10 million cancer-related mortalities and approximately 19.3 million new cancer cases were diagnosed globally. Breast cancer is the most common type of cancer contributing about 11.7% of all cancer types followed by lung cancer (11.4%), colorectal cancer (10.0%), prostate cancer (7.3%) and stomach cancer (5.6%). In addition, the growing prevalence of cancer coupled with the demand for adequate treatment plans for better clinical outcomes is also anticipated to accelerate the growth of the market for treatment planning systems and advanced image processing.

The growing popularity of radiotherapy for the diagnosis and treatment of cancer is one of the prominent factors for the growth of the market for treatment planning systems and advanced image processing. According to an article published by the American Cancer Society in June 2019, about half (49%) of the early-stage breast cancer patients undergo breast-conserving surgery (BCS) with adjuvant radiation therapy for the treatment due to its increased efficiency. In addition, several government initiatives to develop modern healthcare infrastructure for the oncology diagnosis using advanced medical imaging technology are further anticipated to accelerate market growth over the years.

The Role of AI

The increasing adoption of artificial intelligence and machine learning by the market players to develop oncology software solutions to enhance treatment plans, diagnosis and management of cancer is further supporting to the growth of the market for treatment planning systems and advanced image processing. In addition, the increasing initiatives and projects were undertaken to develop health information learning platforms to support improved quality of care for oncology which is also anticipated to boost market growth.

Component Insights

The treatment planning software segment accounted for the highest revenue share of 88.1% in 2021. This high segment share is attributable to the growing prevalence of cancer and increasing demand for accurate and advanced oncology therapy solutions. The increasing awareness regarding the adoption of treatment planning software solutions due to its efficiency in cancer treatment using radiotherapy is further propelling the growth of the segment. In addition, advancements in healthcare infrastructure, increasing public-private partnerships, and preference to use software solutions over conventional practice are some of the major factors attributable to the high revenue share of the segment.

However, the highest growth rate is the advanced image processing software segment during the forecast period. The increasing demand for radiology procedures for the diagnosis and treatment of cancer and the growing adoption of advanced medical imaging solutions are anticipated to boost the segment growth over the years. The increasing number of imaging modalities and growing modern radiology facilities all over the globe with AI-incorporated advanced image processing software are further anticipated to accelerate the growth of the segment. In addition, the shortage of trained radiology professionals is further boosting the demand for advanced image processing solutions.

View the Treatment Planning Systems Comparison Chart


Related Content

News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
News | Lung Imaging

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global ...

Time June 11, 2025
arrow
News | Radiology Imaging

June 10, 2025 — CIVIE has announced the official launch of RadPod, an AI-driven, on-demand radiology platform designed ...

Time June 10, 2025
arrow
News | Ultrasound Imaging

June 4, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time June 09, 2025
arrow
News | Mammography

June 9, 2025 — A new independent, peer-reviewed study published in the journal Clinical Breast Cancer reinforces the ...

Time June 09, 2025
arrow
News | Imaging Software Development

June 05, 2025 — Nano-X Imaging Ltd. has announced that its deep-learning medical imaging analytics subsidiary, Nanox AI ...

Time June 05, 2025
arrow
News | Prostate Cancer

June 5, 2025 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time June 05, 2025
arrow
Subscribe Now